Hongjian Pharmaceutical

Hongjian Pharmaceutical (Shanghai) Co., Ltd. is a leading Chinese pharmaceutical company focused on the development, manufacture, and commercialization of steroid hormone drugs and reproductive health products. As a wholly-owned subsidiary of Shanghai New Hualian Pharmaceutical, the company inherits a legacy of pharmaceutical excellence dating back to 1939. Hongjian Pharmaceutical operates state-of-the-art, GMP-certified manufacturing facilities in the Shanghai Free Trade Zone, producing a wide range of active pharmaceutical ingredients (APIs) and finished dosage forms. Its core product portfolio includes well-known hormonal therapies such as Mifepristone, Nilestriol, and Dexamethasone, many of which are exported globally and hold certifications from the US FDA and European EDQM. The company is dedicated to advancing endocrine and reproductive medicine through high-quality synthesis and innovative manufacturing processes.